TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome (Q66546689)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome |
clinical trial |
Statements
Phase 1B Trial: Evaluation of the Safety of Adding Brentuximab Vedotin to Low-Dose Total Skin Electron Beam (TSEB) for Treatment of Patients With Mycosis Fungoides and Sézary Syndrome (English)
0 references
19 December 2016
0 references
31 August 2020
0 references
5
0 references
18 year
0 references